These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood. Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157 [TBL] [Abstract][Full Text] [Related]
3. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314 [No Abstract] [Full Text] [Related]
4. [Considerations on some cases of acute lymphatic leukemia treated with aspecific active immunotheraphy]. Saggese V; Zanda G Minerva Pediatr; 1974 Jun; 26(21):1087-93. PubMed ID: 4526571 [No Abstract] [Full Text] [Related]
5. [Active immunotherapy in acute lymphoid leukemia in children. Influence of several factors on the results]. Mathe G; Pouillart P; Schwarzenberg L; Hayat M; Schneider M; Weiner R; Amiel JL; Jasmin G; de Vassal F; Cattan A Arch Fr Pediatr; 1973 Jan; 30(1):65-81. PubMed ID: 4516058 [No Abstract] [Full Text] [Related]
6. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer. Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074 [No Abstract] [Full Text] [Related]
7. Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine. Mathé G; Amiel JL; Schwarzenberg L; Schneider M; Hayat M; de Vassal F; Jasmin C; Rosenfeld C; Pouillart P Rev Eur Etud Clin Biol; 1971 Mar; 16(3):216-24. PubMed ID: 4997294 [No Abstract] [Full Text] [Related]
8. Treatment of the acute leukemias. Bernard J; Jacquillat C; Weil M Semin Hematol; 1972 Apr; 9(2):181-91. PubMed ID: 4553226 [No Abstract] [Full Text] [Related]
9. Results in children of acute lymphoid leukemia: protocol ICIG-ALL 9 consisting of chemotherapy for only 9 months followed by active immunotherapy: comparison with the results of more prolonged chemotherapy protocols. Recognition of two groups of acute lymphoid leukemias from prognostic parameters. Mathé G; De Vassal F; Schwarzenberg L; Gil MA; Delgado M; Weiner R; Pena-Angulo J; Belpomme D; Pouillart P; Machover D; Misset JL; Pico JL; Jasmin C; Hayat M; Schneider M; Cattan A; Amiel JL; Musset M; Rosenfeld C Recent Results Cancer Res; 1977; (62):67-77. PubMed ID: 341251 [No Abstract] [Full Text] [Related]
10. [Attempts at treatment of acute leukemia with L-asparaginase]. Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225 [No Abstract] [Full Text] [Related]
11. [Immunotherapy of cancer with BCG]. Yamamura Y; Azuma I Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604 [No Abstract] [Full Text] [Related]
13. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice. Chaparas SD; Chirigos M; Pearson J; Sher N Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328 [No Abstract] [Full Text] [Related]
14. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters. Miale TD; Yocum D; Yocum C Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382 [TBL] [Abstract][Full Text] [Related]
15. Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function. Ekert H; Jose DG; Wilson FC; Matthews RN; Lay H Int J Cancer; 1975 Jul; 16(1):103-12. PubMed ID: 1058172 [TBL] [Abstract][Full Text] [Related]
16. Active specific immunotherapy for acute myelogenous leukaemia. Powles R Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353 [No Abstract] [Full Text] [Related]
17. A clinical trial of chemotherapy and RAJI immunotherapy in advanced acute lymphatic leukemia. Sacks KL; Olweny C; Mann DL; Simon R; Johnson GE; Poplack DG; Leventhal BG Cancer Res; 1975 Dec; 35(12):3715-20. PubMed ID: 127655 [TBL] [Abstract][Full Text] [Related]
18. [Immunological control over the action of BCG vaccine in the chemoimmunotherapy of acute leukemia in children]. Kisliak NS; Averbakh MM; Bergolts VM; Moroz AM; Eremeev VS Sov Med; 1978 Nov; (11):35-8. PubMed ID: 364684 [No Abstract] [Full Text] [Related]
19. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy]. Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404 [TBL] [Abstract][Full Text] [Related]
20. Attempts at immunotherapy of 100 patients with acute lymphoid leukemia: some factors influencing results. Mathé G; Pouillart P; Schwarzenberg L; Amiel JL; Schneider M; Hayat M; De Vassal F; Jasmin C; Rosenfeld C; Weiner R; Rappaport H Natl Cancer Inst Monogr; 1972 Dec; 35():361-72. PubMed ID: 4512322 [No Abstract] [Full Text] [Related] [Next] [New Search]